Children's Hosiptal of Eastern Ontario
Ottawa, Ontario, K1H 8L1, Canada
NCT Number: NCT00542334
This study will help determine the frequency and magnitude of nocturnal hypoglycemia (low blood sugar at night during sleep), in children with type 1 diabetes who are on a standard insulin regimen, by using a Continuous Glucose Monitoring System (CGMS). Secondary objectives include the establishment of a definition of nocturnal hypoglycemia for the CGMS and for the calculation of sample size needed for future studies using CGMS. Nocturnal hypoglycemia (NH) can be associated with significant morbidity including seizure and coma. The investigators intend to use the CGMS in a future study investigating the use of a new insulin combination aimed to decrease the frequency of NH in the pediatric population.
Thirty pediatric subjects with established type 1 diabetes mellitus will be asked to wear a CGMS for 3 days. During this time the participants will be required to test and record self-monitored blood glucose readings at designated time periods and if they have symptoms of hypoglycemia. The comparison of these values with each other and with different previously defined values of NH will allow for a clear definition of NH to be made. A survey has also been designed to assess participant satisfaction with the CGMS.
Looking for future studies?
Notify Me2 year–18 year
All sexes
Observational
Ottawa, Ontario, K1H 8L1, Canada
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 3 days
Time frame: 3 days
Children's Hospital of Eastern Ontario
Other
Prevalence of Nocturnal Hypoglycemia in Children and Adolescents With Type 1 Diabetes on a Standard (TID) Insulin Regimen Using a Continuous Glucose Monitoring System (CGMS) - A Pilot Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02225379
Autoimmune Diseases, Diabetes Mellitus
Petah Tikva, Israel
View Trial DetailsNCT02192450
Autoimmune Diseases, Diabetes Mellitus
Hilleroed, Denmark
View Trial DetailsNCT03215914
Glucose Metabolism Disorders, Hypoglycemia
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT02299479
Diabetes, Diabetes Mellitus
Boston, Massachusetts, United States
View Trial Details